Skip to content

STRICTuring Crohn’s disease assessment using advanced Ultrasound and magnetic REsonance imaging techniques for evaluation of inflammation and fibrosis

STRICTuring Crohn’s disease assessment using advanced Ultrasound and magnetic REsonance imaging techniques for evaluation of inflammation and fibrosis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON24793
Enrollment
54
Registered
2020-12-07
Start date
2019-12-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn's Disease

Interventions

None

Sponsors

none
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • Endoscopic or histological confirmed Crohn’s Disease • Age = 18 year • One or more small bowel stricture(s) confirmed on endoscopy and/or cross-sectional imaging • Scheduled for anti-inflammatory treatment or surgery

Exclusion criteria

Exclusion criteria: • Isolated colonic stricture • Endoscopic balloon dilation prior to baseline MRI or ultrasonography • Pregnancy • Age <18years • Inability to give informed consent • Ongoing gastroenteritis • No stricture visible on ultrasound and/or MRI • Specifically for MRI o General contraindications for MRI (MRI-incompatible implants, pacemaker, claustrophobia, and pregnancy) • Specifically for CEUS o Chronic obstructive lung disease o Acute coronary heart disease o Clinically unstable heart disease o Previous allergic reaction to Sonovue or to its components

Design outcomes

Primary

MeasureTime frame
MRI: -MT-ratio -IVIM fractional perfusion -T2*-value -Quantitated intestinal motility Ultrasound: -Speed of velocity of shear-wave (m/s) -Mean transit time of intravascular contrast (s) -Time to peak (s) -Blood volume per tissue (mL/100 mL tissue) -Blood flow (m/s) -Time between arrival of oral contrast at the stricture and passage through the stricture -Number of bowel movements before oral contrast passes through the stricture Clinical: -Response to therapy after 26 weeks of treatment (defined by the continuation of baseline medical therapy without adding other anti-inflammatory medication, the absence of the need for an intervention (balloon dilation or surgery) and no clinical deterioration based on clinical activity indices9,31) Histopathology: -Inflammation grades -Fibrosis grades

Secondary

MeasureTime frame
- Conventional MRI parameters: length of the stricture, prestenotic dilatation, bowel wall thickness, bowel wall edema, bowel wall enhancement and stratification, fatty wrapping, presence of lymph nodes, fistulas and abscesses. - Conventional ultrasound parameters: length of the stricture, prestenotic dilation, bowel wall thickness, wall layer stratification, fatty wrapping, Doppler signal, motility, presence of lymph nodes, abscesses, fistulas. - Clinical information: medical history, sex, age, weight, height, current and previous medication - Clinical activity scores: Harvey-Bradshaw Index31 (HBI) and Crohn’s Disease Obstructive Score9 (CDOS) - Blood: C-reactive protein, hemoglobin, platelet count, leukocyte count, erythrocyte count and albumin - Faecal calprotectin

Contacts

Public ContactFloris de Voogd

Amsterdam UMC/AMC

f.a.devoogd@amsterdamumc.nl020-5661922

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)